Early Bird 50% Discount Before September 1, 2023 TORONTO ON — StarFish Medical announces the return of Medical Device Playbook to Toronto’s MaRS DD on October 19, 2023, from 9am to… Read More
Frontage Laboratories, Inc. and its wholly-owned subsidiary, Frontage Canada, Inc., completed the acquisition of Nucro-Technics Inc. and its affiliate Nucro-Technics Holdings, Inc. Nucro-Technics is a pharmaceutical contract research organization that conducts… Read More
SignalChem Announces Patients Enrollment in Clinical Trial of AXL Inhibitor SLC-391 in Combination with KEYTRUDA® (pembrolizumab) for Advanced or Metastatic Non-Small Cell Lung Cancer VANCOUVER, BC — SignalChem Lifesciences Corp. is… Read More
Agreement provides nonexclusive access to Genevant’s leading LNP technology for use with Gritstone bio’s self-amplifying RNA technology in wide array of infectious disease vaccines Multi-year, multi-pathogen, option-based deal follows multiple successful… Read More
By the time people are diagnosed with mild chronic obstructive pulmonary disease (COPD)—a condition that obstructs airflow in the lungs—more than 40 per cent of the smallest airways in their… Read More
